Skip to main content
SpringerLink
Log in

Intravesical bacillus Calmette-Guérin administration in the prophylaxis of superficial bladder cancer

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

A total of 68 patients received prophylactic/adjuvant intravesical Pasteur strain bacillus Calmette-Guérin (BCG) instillations following transurethral resection for superficial bladder carcinoma. An induction phase consisting of 6 weekly instillations was followed by a maintenance phase consisting of 1 instillation given every 3 months. A second 6-week course of BCG was administered to initial failure followed again by a quarterly maintenance therapy. The response rate for patients treated with one 6-week course was 56%, while complete response was achieved in 72% when both treatment courses were considered. Follow-up period lasted at least 2 years after each course of BCG. These results suggest that additional courses of BCG increase the prophylactic efficacy of intracavitary BCG. Regarding the purified protein derivative (PPD) skin test and granulomatous response in the bladder, it has been shown in the present study that, although favourable results occurred more frequently among patients with either PPD conversion from negative to positive or vesical granuloma formation, neither of these indices should be considered reliable prognostic indicators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adolphs, H.-D., Bastian, H. P.: Chemoimmune prophylaxis of superficial bladder tumors: Results after treatment of more than 130 patients in 4 years. Read at annual meeting of American Urological Association, Las Vegas, Nevada 1983. Abstract 347, p. 178.

  2. Badalament, R. A., Herr, H. W., Wong, G. Y., Gnecco, C., Pinsky, L. M., Whitmore, W. F. Jr., Fair, W. R., Oettgen, H. F.: A prospective randomized trial of maintenance versus nonmaintenance bacillus Calmette-Guérin therapy of superficial bladder cancer.J. Clin. Oncol., 5, 441 (1987).

    PubMed  CAS  Google Scholar 

  3. Brendler, C. B., Alexander, R. B.: Treatment of recurrent superficial transitional cell carcinoma of the bladder with intravesical bacillus Calmette-Guérin (BCG).J. Urol., 135, 184A, Part 2, Abstract 720 (1986).

    Google Scholar 

  4. Brosman, S. A.: Experience with bacillus Calmette-Guérin in patients with superficial bladder carcinoma.J. Urol., 128, 27 (1982).

    PubMed  CAS  Google Scholar 

  5. Catalona, W. J., Hudson, M. A., Gillen, D. P., Andriole, G. L., Ratliff, T. L.: Risks and benefits of repeated courses of intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer.J. Urol., 137, 220 (1987).

    PubMed  CAS  Google Scholar 

  6. Cumming, J. A., Hargreave, T. B., Webb, J. N., McIntyre, M. A., Chisholm, G. D.: Intravesical Evans bacillus Calmette-Guérin in the treatment of carcinoma in situ.Br. J. Urol., 63, 259 (1989).

    Article  PubMed  CAS  Google Scholar 

  7. Haaff, E. O., Dresner, S. M., Ratliff, T. L., Catalona, W. J.: Two courses of intravesical bacillus Calmette-Guérin for transitional cell carcinoma of the bladder.J. Urol., 136, 820 (1986).

    PubMed  CAS  Google Scholar 

  8. Heney, N. M., Koontz, W. W., Weinstein, R., Burton, B.: BCG for superficial bladder carcinoma.J. Urol., 135, 184 A, Part 2, Abstract 321 (1986).

    Google Scholar 

  9. Herr, H. W., Pinsky, C. M., Whitmore, W. F. Jr., Sogani, P. G., Oettgen, H. F., Melamed, M. R.: Experience with intravesical bacillus Calmette-Guérin therapy of superficial bladder tumors.Urology, 25, 119 (1985).

    Article  PubMed  CAS  Google Scholar 

  10. Herr, H. W.: Re: Two courses of intravesical bacillus Calmette-Guérin for transitional cell carcinoma of the bladder. Letter to the Editor.J. Urol., 138, 409 (1987).

    PubMed  CAS  Google Scholar 

  11. Hudson, M. A., Ratliff, T. L., Gillen, D. R., Haaff, E. O., Dresner S. M., Catalona, W. J.: Single course versus maintenance bacillus Calmette-Guérin therapy for superficial bladder tumors: A prospective randomized trial.J. Urol., 138, 295 (1987).

    PubMed  CAS  Google Scholar 

  12. Kavoussi, L. R., Torrence, R. J., Gillen, D. P., Hudson, M. A., Haaff, E. O., Dresner, S. M., Ratliff, T. L., Catalona, W. J.: Results of 6 weekly intravesical bacillus Calmette-Guérin instillations in the treatment of superficial bladder tumors.J. Urol., 139, 935 (1988).

    PubMed  CAS  Google Scholar 

  13. Kelley, D. R., Ratliff, T. L., Catalona, W. J., Shapiro, A., Lage, J. M., Bauer, W. C., Haaff, E. O., Dresner, S. M.: Intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer: Effect of bacillus Calmette-Guérin viability on treatment results.J. Urol., 134, 48 (1985).

    PubMed  CAS  Google Scholar 

  14. Kelley, D. R., Haaff, E. O., Becich, M., Lage, J. M., Bauer, W. C., Dresner, S. M., Catalona, W. J., Ratliff, T. L.: Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guérin.J. Urol., 135, 268 (1986).

    PubMed  CAS  Google Scholar 

  15. Khanna, O. P., Chou, R. H., Son, D. C., Mazer, H., Read, J., Nugent, D., Cottone, R., Heeg, M., Rezvan, M., Viek, N., Uhlman, R., Friedmann, M.: Does bacillus Calmette-Guérin immunotherapy accelerate growth and cause metastatic spread of second primary malignancy?Urology, 31, 459 (1988).

    Article  PubMed  CAS  Google Scholar 

  16. Lamm, D. L., Thor, D. E., Harris, S. C., Reyna, J. A., Stogdill, V. D., Radwin, H. M.: Bacillus Calmette-Guérin immunotherapy of superficial bladder cancer.J. Urol., 124, 38 (1980).

    PubMed  CAS  Google Scholar 

  17. Lamm, D. L.: Bacillus Calmette-Guérin immunotherapy for bladder cancer.J. Urol., 134, 40 (1985).

    PubMed  CAS  Google Scholar 

  18. Morales, A., Eidinger, D., Bruce, A. W.: Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumor.J. Urol., 116, 180 (1976).

    PubMed  CAS  Google Scholar 

  19. Morales, A.: Long-term results and complications of intracavitary bacillus Calmette-Guérin therapy for bladder cancer.J. Urol., 132, 457 (1984).

    PubMed  CAS  Google Scholar 

  20. Otto, U., Huland, H., Klosterhalfen, H.: Rezidivprophylaxe oberflächlicher Blasenkarzinome—Literaturübersicht. In: Therapie und Rezidivprophylaxe oberflächlicher Harnblasenkarzinome. Georg Thieme Verlag, New York 1984.

    Google Scholar 

  21. Pinsky, C. M., Camacho, F. J., Kerr, D., Geller, N. L., Klein, F. A., Herr, H. W., Whitmore, W. F. Jr., Oettgen, H. F.: Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: Report of a prospective randomized trial.Cancer Treat. Rep., 69, 47 (1985).

    PubMed  CAS  Google Scholar 

  22. Schellhammer, P. F., Ladaga, L. E., Fillion, M. B.: Bacillus Calmette-Guérin for superficial transitional cell carcinoma of the bladder.J. Urol., 135, 261 (1986).

    PubMed  CAS  Google Scholar 

  23. Soloway, M. S., Murphy, W. M., Perry, A.: BCG treatment for Thiotepa or Mitomycin C failures.J. Urol., 135, 184A, Part 2, Abstract 323 (1986).

    Google Scholar 

  24. Torrence, R. J., Kavoussi, L. R., Catalona, W. J., Ratliff, T. L.: Prognostic factors in patients treated with intravesical Calmette-Guérin for superficial bladder cancer.J. Urol., 139, 941 (1988).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Patras University School of Medicine, Rio-Patras, Greece

    M. D. Melekos, A. Pantazakos, S. Markou, A. Athanassopoulos & G. Barbalias

  2. Department of Pathology, Patras University School of Medicine, Rio-Patras, Greece

    C. Skopa

Authors
  1. M. D. Melekos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Pantazakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Markou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Skopa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Athanassopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Barbalias
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melekos, M.D., Pantazakos, A., Markou, S. et al. Intravesical bacillus Calmette-Guérin administration in the prophylaxis of superficial bladder cancer. International Urology and Nephrology 22, 433–440 (1990). https://doi.org/10.1007/BF02549774

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02549774

Keywords

Search

Navigation